* The Food and Drug Administration is requiring the manufacturer of fenofibric acid (Trilipix), also called fenofibrate, to complete a clinical trial to determine the drug's efficacy in reducing cardiovascular events in patients with type 2 diabetes who are already taking a statin.Diane S. ...
136TriLipix - will Abbott's fenofibrate continue the domination? 139Surrogate end points in dyslipidemia - a matter of the past? 140ILLUMINATE puts HDL cholesterol into the spotlight 140Torcetrapib's fiasco 140Price